Analgesics Market 2025–2029: Strategic Opportunities and Growth Insights

Uncover key drivers, emerging technologies, and competitive movements shaping the analgesics market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Analgesics Market Now And By 2029?

The analgesics market has demonstrated consistent expansion over recent years. It is anticipated to increase from $110.47 billion in 2024 to $113.1 billion in 2025, achieving a compound annual growth rate (CAGR) of 2.4%. Key factors driving this historic growth include alternative therapies impact, safety and efficacy studies, pain prevalence, marketing and promotion, and economic factors.

The analgesics market is projected to observe consistent expansion in the upcoming years. Its size is expected to reach $127.81 billion by 2029, achieving a compound annual growth rate (CAGR) of 3.1%. This anticipated growth is primarily driven by factors such as various pain management alternatives, heightened market competition, increasing consumer health awareness, evolving demographic patterns, and the rising prevalence of chronic diseases. Prominent trends identified for this forecast period encompass personalized medicine, the development of non-opioid alternatives, the incorporation of CBD and cannabinoids, advanced targeted pain management approaches, and improvements in accessibility and affordability.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2438&type=smp

Which Long-Term Drivers Are Expected To Sustain The Analgesics Market?

The analgesics Market is being propelled by a notable increase in the occurrence of chronic diseases. These drugs, commonly referred to as painkillers, are employed to alleviate and lessen chronic or intense bodily discomfort stemming from diverse health issues. As an illustration, a report released in September 2022 by WHO, a health organization based in Switzerland, elucidated that chronic diseases, also known as noncommunicable diseases (NCDs), are long-term conditions that result from a mix of genetic, physiological, environmental, and behavioral factors. Globally, NCDs are responsible for 41 million deaths annually, making up 74% of all deaths. Annually, 17 million individuals worldwide die from an NCD prior to reaching the age of 70. Such premature deaths constitute 86% of all deaths reported in low- and middle-income countries. Furthermore, 77% of all fatalities linked to NCDs happen in these same nations. Consequently, the substantial increase in the prevalence of chronic disease is a key factor fueling the expansion of the analgesics market.

How Is The Analgesics Market Classified By Different Segments?

The analgesics market covered in this report is segmented –

1) By Type: Non-opioids, Opioids

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores

3) By Application: Internal Analgesics, External Analgesics

Subsegments:

1) By Non-Opioids: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen (Paracetamol), Salicylates

2) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids

What Current And Upcoming Trends Are Shaping The Analgesics Market?

Businesses within the analgesics market are increasingly prioritizing investment as a key strategy for expansion. Leading manufacturers of analgesic drugs are channeling capital into clinical-stage companies to achieve a competitive edge and strengthen their market standing. These investments assist companies in broadening their geographical reach and acquiring specialized expertise in the research and development of new products. For example, in January 2022, Concentric Analgesics, Inc., a US-based clinical-stage biopharmaceutical company, announced the completion of a $20 million convertible note financing, secured from a mix of new and existing investors. This funding is intended to initiate registration-enabling Phase 3 studies for Vocacapsaicin, the company’s flagship product candidate that is ready for Phase 3. The financing will also be utilized to further support Phase 3 development activities for Vocacapsaicin, which is Concentric Analgesics’ primary therapeutic candidate for post-surgical pain. The successful completion of this financing represents a vital development for Concentric Analgesics, as it allows the company to continue advancing Vocacapsaicin into Phase 3 development and serves as an important initial step towards fully funding the program all the way through NDA submission.

Who Are The Primary Market Leaders In The Analgesics Market?

Major companies operating in the analgesics market include Pfizer Inc., Johnson & Johnson Services Inc., Medley Pharmaceuticals Limited, AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical company Limited, Eli Lilly and Company, Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Limited, Purdue Pharma L.P, Cipla Limited, Allergan Inc., Endo International plc, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals Ltd., Chattem Inc., Hisamitsu Pharmaceutical Co.Inc., GW Pharmaceuticals, Verve Health Care Ltd., Alder BioPharmaceuticals Inc., Achelios Therapeutics Inc., WEX Pharmaceuticals Inc., Zynerba Pharmaceuticals, McNeil Consumer & Specialty Medical Products, Innovative Med Concepts LLC

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/analgesics-global-market-report

Which Regional Markets Are Emerging As Key Centers For The Analgesics Market?

North America was the largest region in the analgesics market in 2024. Middle East is expected to be the fastest-growing region in the global analgesics market during the forecast period. The regions covered in the analgesics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=2438&type=smp

Browse Through More Reports Similar to the Global Analgesics Market 2025, By The Business Research Company

Anti Infective Drugs Market 2025

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

Hospital Acquired Infections Testing Kits Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Dermatology Medical Lasers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-medical-lasers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795